MeDirect Bank (Malta) plc would like to announce that we are accepting applications for anyone interested in the new bond issue by Phoenicia Finance Company p.l.c. (the “Issuer”).
Phoenicia Finance Company p.l.c. has announced the issue of €50,000,000 Unsecured bonds at 5.75% at a nominal value of €100 per bond, redeemable in 2028 – 2033 (the “Bond Issue”), following approval by the Listing Authority.
In the case of Existing Bondholders, a minimum of €100 and multiples of €100 thereafter shall apply. In all other cases a minimum of €2,000 and multiples of €100 thereafter. The interest rate of 5.75 per cent will be paid annually on 30 December.
The use of the bond proceeds will consist of:
- an amount of up to €25,000,000 in Existing Bonds will be acquired via transfer to the Issuer by Existing Bondholders in consideration for the subscription of Bonds, resulting in the cancellation of such Existing Bonds and giving rise to obligations on the part of the Issuer under the Bonds.
- an amount of up to €24,050,000 will be advanced by the Issuer to PML pursuant to the Loan Agreement, in terms of which PML has delegated the Issuer to pay such amount to APS Bank p.l.c. to re-pay (in whole or in part) the APS Loan I.
Full details about this Bond Issue are set out in the Prospectus dated 8 February 2024 which can be found here.
MeDirect will be accepting applications from anyone, who is interested. All applications must be received by not later 23 February 2024. In the event of over-subscription, the Issuer reserves the right to close the Offer Period before this date.
MeDirect will be accepting applications from anyone, who is interested. All applications must be received by not later 9 February 2024. In the event of over-subscription, the Issuer reserves the right to close the Offer Period before this date.
If you are interested in applying, please send us a Secure Mail or contact your Relationship Manager.
For further information, please call us on (+356) 2557 4400 or send an email to customerservice@medirect.com.mt.
The information set forth in this article is only for informative purposes and should not be construed as an offer to sell or solicitation of an offer to subscribe for or purchase any investment. The information provided is subject to change without notice and does not constitute investment advice or any guarantee of returns.
Please consider the terms and conditions governing the relevant investment prior to making any investment decision. Investors should note that at worst they may lose all of their invested principal in the event of default, insolvency and/or bankruptcy of the relevant issue. The financial instruments discussed may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.
MeDirect Bank (Malta) plc has based this document on information obtained from sources it believes to be reliable but which have not been independently verified. MeDirect Bank (Malta) plc does not therefore provide any guarantees, representations or warranties. The value of any investment or income may go up as well as down and past performance is no guarantee of any future performance. When an investment is denominated in a currency other than your local or reporting currency, changes in exchange rates may have an adverse effect on your investment.
MeDirect Bank (Malta) plc, company registration number C34125, is licensed by the Malta Financial Services Authority under the Banking Act (Cap. 371) and the Investment Services Act (Cap. 370). This material is intended only for the use of the recipient and shall not be reproduced in any way, whether in whole or in part, by the recipient. Any unauthorised disclosure, use or dissemination, either in whole or in part, of the material contained within is strictly prohibited.